Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nurix Therapeutics Inc (NQ: NRIX ) 25.20 +0.20 (+0.80%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nurix Therapeutics Inc < Previous 1 2 3 Next > The Latest Analyst Ratings for Nurix Therapeutics October 13, 2023 Via Benzinga Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today? September 07, 2023 Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called... Via Benzinga What 4 Analyst Ratings Have To Say About Nurix Therapeutics September 07, 2023 Via Benzinga Designer Brands, Calavo Growers, Couchbase And Other Big Stocks Moving Higher On Thursday September 07, 2023 U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data July 24, 2023 HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX) Via Benzinga Analyst Ratings for Nurix Therapeutics July 24, 2023 Via Benzinga Nurix Therapeutics's Return On Capital Employed Insights July 14, 2023 Via Benzinga Analyst Ratings for Nurix Therapeutics April 14, 2023 Via Benzinga Nurix Therapeutics Inc. (NASDAQ: NRIX) Highlighted for Surprising Price Action April 13, 2023 Via Investor Brand Network Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday July 14, 2023 It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday! Via InvestorPlace JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday April 14, 2023 U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Expert Ratings for Nurix Therapeutics March 21, 2023 Via Benzinga Gilead Exercises First License Option Under Agreement With Nurix Therapeutics March 20, 2023 Via Benzinga Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479 March 20, 2023 From Gilead Sciences, Inc. Via Business Wire Analyst Ratings for Nurix Therapeutics February 28, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023 March 09, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 February 28, 2023 Via Benzinga Nurix Therapeutics's Return On Capital Employed Overview February 14, 2023 Via Benzinga Where Nurix Therapeutics Stands With Analysts July 08, 2022 Within the last quarter, Nurix Therapeutics (NASDAQ:NRIX) has observed the following analyst ratings: Via Benzinga The Top 5 Stocks Cathie Wood Bought and Sold This Week October 21, 2022 Cathie Wood's flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager. Via InvestorPlace CSX, Veris Residential And Some Other Big Stocks Moving Higher In Today's Pre-Market Session October 21, 2022 U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company October 10, 2022 Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the Via Benzinga Top Russell 2000 Stocks: Trading Opportunities For Next Week - Sunday, Sept. 11 September 11, 2022 A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some Russell 2000 stock... Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022 October 11, 2022 Upgrades Via Benzinga Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday September 21, 2022 Gainers Via Benzinga Why Nurix Therapeutics Shares Are Rising Today July 08, 2022 Nurix Therapeutics Inc (NASDAQ: NRIX) shares are trading higher by 13.25% to $17.52 Friday afternoon after the company announced a registered direct offering for total gross proceeds of approximately... Via Benzinga Tesla, Twitter And 76 Biggest Movers From Friday July 11, 2022 Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... Via Benzinga Nurix Therapeutics's Return On Capital Employed Insights July 08, 2022 Benzinga Pro data, Nurix Therapeutics (NASDAQ:NRIX) reported Q2 sales of $11.43 million. Earnings fell to a loss of $45.40 million, resulting in a 6.74% decrease from last quarter. Via Benzinga The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug July 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 69 Biggest Movers From Friday June 06, 2022 Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.